These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 1542493

  • 1. Effect of chemotherapy on colony-forming unit-granulocyte macrophage from bone marrow and peripheral blood in patients with lung cancer.
    Mukai J, Shimizu E, Takaue Y, Ogura T.
    Oncology; 1992; 49(1):45-8. PubMed ID: 1542493
    [Abstract] [Full Text] [Related]

  • 2. Granulocyte-colony-stimulating factor enhances the circulating hematopoietic progenitors in lung cancer patients treated with cisplatin-containing regimens.
    Mukai J, Shimizu E, Ogura T.
    Jpn J Cancer Res; 1992 Jul; 83(7):746-53. PubMed ID: 1381342
    [Abstract] [Full Text] [Related]

  • 3. Effect of alternating combination chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, cisplatin, and etoposide for small cell lung cancer on hematopoietic progenitors in the peripheral blood.
    Shimizu E, Yamamoto A, Takahashi Y, Maniwa K, Yoshida S, Mukai J, Takaue Y, Ogura T.
    Br J Cancer; 1993 Apr; 67(4):798-800. PubMed ID: 8385979
    [Abstract] [Full Text] [Related]

  • 4. Circulating hematopoietic progenitors in patients with primary lung cancer.
    Shimizu E, Mukai JN, Takaue Y, Ogura T.
    Jpn J Cancer Res; 1990 Dec; 81(12):1293-9. PubMed ID: 2125998
    [Abstract] [Full Text] [Related]

  • 5. EFFICIENCY OF BONE MARROW PRECURSOR CELL COLONY-FORMING AS A PREDICTOR OF DISEASE COURSE IN PLASMA CELL MYELOMA PATIENTS WITH A HISTORY OF RADIATION EXPOSURE.
    Minchenko ZM, Liubarets TF, Balan VV, Dmytrenko OO, Shlyakhtichenko TY, Moyseyenko VO, Silayev YO, Bebeshko VG.
    Probl Radiac Med Radiobiol; 2020 Dec; 25():490-501. PubMed ID: 33361856
    [Abstract] [Full Text] [Related]

  • 6. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 7. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 8. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
    Tanikawa S, Nakao I, Tsuneoka K, Nara N.
    Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
    [Abstract] [Full Text] [Related]

  • 9. Circulating myeloid progenitor cell kinetics during hematologic recovery from chemotherapy and subsequent recombinant human granulocyte-macrophage colony-stimulating factor administration.
    Ventura GJ, Reading CL, Hester JP, Vadhan-Raj S.
    Acta Haematol; 1990 Sep; 84(4):175-81. PubMed ID: 2125781
    [Abstract] [Full Text] [Related]

  • 10. Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF.
    Ballestrero A, Ferrando F, Garuti A, Basta P, Gonella R, Stura P, Mela GS, Sessarego M, Gobbi M, Patrone F.
    J Clin Oncol; 1999 Apr; 17(4):1296. PubMed ID: 10561192
    [Abstract] [Full Text] [Related]

  • 11. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S.
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [Abstract] [Full Text] [Related]

  • 12. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
    Brandwein JM, Nayar R, Baker MA, Sutton DM, Scott JG, Sutcliffe SB, Keating A.
    Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
    [Abstract] [Full Text] [Related]

  • 13. Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factor.
    Hestdal K, Jacobsen SE, Ruscetti FW, Longo DL, Boone TC, Keller JR.
    Exp Hematol; 1993 Jun; 21(6):799-805. PubMed ID: 8500577
    [Abstract] [Full Text] [Related]

  • 14. Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells.
    Lagneaux L, Delforge A, Snoeck R, Stryckmans P, Bron D.
    Exp Hematol; 1994 Jan; 22(1):26-30. PubMed ID: 7506672
    [Abstract] [Full Text] [Related]

  • 15. Relationship of infused CFU-GM and CFU-Mk mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation.
    Takamatsu Y, Harada M, Teshima T, Makino S, Inaba S, Akashi K, Shibuya T, Niho Y.
    Exp Hematol; 1995 Jan; 23(1):8-13. PubMed ID: 7527786
    [Abstract] [Full Text] [Related]

  • 16. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor.
    Schwartzberg LS, Birch R, Hazelton B, Tauer KW, Lee P, Altemose R, George C, Blanco R, Wittlin F, Cohen J.
    J Hematother; 1992 Jan; 1(4):317-27. PubMed ID: 1285381
    [Abstract] [Full Text] [Related]

  • 17. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
    Strife A, Lambek C, Perez A, Darzynkiewicz Z, Skierski J, Gulati S, Haley JD, ten Dijke P, Iwata KK, Clarkson BD.
    Cancer Res; 1991 Sep 15; 51(18):4828-36. PubMed ID: 1893375
    [Abstract] [Full Text] [Related]

  • 18. In vitro expansion of CD34+ cells mobilized with chemotherapy and G-CSF.
    Teofili L, Iovino MS, Di Mario A, Ortu La Barbera E, Pierelli L, Bussa S, Rumi C, Menichella G, Leone G.
    Int J Artif Organs; 1993 Dec 15; 16 Suppl 5():89-95. PubMed ID: 7516922
    [Abstract] [Full Text] [Related]

  • 19. Peripheral blood stem cells harvested after chemotherapy and GM-CSF for treatment intensification in patients with advanced lymphoproliferative diseases.
    Campos L, Bastion Y, Roubi N, Felman P, Espinouse D, Dumontet C, Debost M, Tremisi JP, Coiffier B.
    Leukemia; 1993 Sep 15; 7(9):1409-15. PubMed ID: 8103811
    [Abstract] [Full Text] [Related]

  • 20. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
    Ido M, Harada M, Furuichi H, Matsuoka N, Nakano K, Sohmura Y.
    Exp Hematol; 1992 Feb 15; 20(2):161-6. PubMed ID: 1371964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.